Gutscheinbedingungen

*Gültig bis 07.06.2026 auf (fast) alles. Ausgeschlossen sind Smartboxen, Zeitschriften, Tickets, Lebensmittel, Gaming-Elektroartikel, Tinte/Toner, Gutscheine, Geschenkkarten, Blumen und Abos | Einlösbar in allen Buchhandlungen von Orell Füssli, Barth Bücher, Buchladen Rapunzel, Schuler Orell Füssli, Stauffacher und ZAP unter Vorweisung des Gutscheins, auf www.orellfüssli.ch durch Eingabe des Gutscheincodes. Beim Service „eBooks verschenken“ und bei eBook-Käufen via eReader nicht einlösbar | Mindesteinkaufswert: Fr. 100.- | Nicht mit anderen Rabatten kumulierbar.

Produktbild: Public Health and Toxicology Issues in Drug Research, Volume 2

Public Health and Toxicology Issues in Drug Research, Volume 2 Toxicity and Toxicodynamics

Fr. 253.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

28.03.2024

Herausgeber

Rakesh K. Tekade

Verlag

Elsevier

Seitenzahl

852

Maße (L/B)

23.5/19.1 cm

Gewicht

1750 g

Sprache

Englisch

ISBN

978-0-443-15842-1

Beschreibung

Portrait

Dr Rakesh K Tekade, Assistant Professor of the Department of Pharmaceutics, investigates the design, development and characterization of targeted nanotechnology based formulations for the site specific delivery of therapeutic drugs, siRNA, microRNA, plasmids, proteins and peptide for the treatment of cancer. His current research encompasses development of novel polymeric nanomaterial for effective cytosolic delivery of anticancer bioactives. Dr Tekade’s research is focused on designing a new generation of nanoparticles, which could identify the cancer cells and selectively deliver anticancer drugs and genes to inhibit the growth of cancer while sparing healthy tissues. His research work involves the applications of polymer chemistry, nanotechnology, molecular biology, pharmacokinetics/pharmacodynamics and imaging techniques. Dr Tekade has over 70 publications, 01 patent, 7 book chapters, and 3 editorial articles. He has delivered several invited research talks and presented research finding in more than 30 scientific conferences.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

28.03.2024

Herausgeber

Rakesh K. Tekade

Verlag

Elsevier

Seitenzahl

852

Maße (L/B)

23.5/19.1 cm

Gewicht

1750 g

Sprache

Englisch

ISBN

978-0-443-15842-1

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

Die Leseprobe wird geladen.
  • Produktbild: Public Health and Toxicology Issues in Drug Research, Volume 2
  • 1. Biomarkers: Revolutionizing disease monitoring and therapeutic strategies
    Anand More, Simranjit Kaur, Sakshi Bhatele, Nupur Vasdev, Tanisha Gupta, Bhakti Pawar and Rakesh Kumar Tekade
    2. Connecting biotransformation with toxicity
    Simranjit Kaur, Muktika Tekade, Bhakti Pawar, Nupur Vasdev, Tanisha Gupta, Nagaraja Sreeharsha and Rakesh Kumar Tekade
    3. Idiosyncratic drug reactions and toxicities
    Tanisha Gupta, Yogesh Wankhede, Muktika Tekade, Amrita Singh, Nupur Vasdev, Bhakti Pawar, Manoj Kumar and Rakesh Kumar Tekade
    4. Importance of dose selection in toxicity studies
    Mamata Panchal, Simranjit Kaur, Bhakti Pawar, Tanisha Gupta, Nupur Vasdev, Muktika Tekade and Rakesh Kumar Tekade
    5. Implication of sex differences in toxicology
    Anand More, Simranjit Kaur, Muktika Tekade, Vipulata Yeole, Prashant L. Pingale, Dattatraya Shinkar and Rakesh Kumar Tekade
    6. Toxicological risk assessment and risk management
    Suresh Shinde, Simranjit Kaur, Muktika Tekade, Bhakti Pawar, Tanisha Gupta, Nupur Vasdev, Basel Arafat and Rakesh Kumar Tekade
    7. Adverse outcome pathway: A paradigm shift in chemical toxicological analysis
    Sakshi Bhatele, Mahi Mhatre, Muktika Tekade, Nupur Vasdev, Bhakti Pawar and Rakesh Kumar Tekade
    8. Design of toxicokinetic studies
    Simranjit Kaur, Muktika Tekade, Nupur Vasdev, Bhakti Pawar, Tanisha Gupta, Aprameya Ganesh Prasad and Rakesh Kumar Tekade
    9. Use of toxicokinetic data in preclinical safety assessment
    Simranjit Kaur, Muktika Tekade, Nupur Vasdev, Bhakti Pawar, Shubham Mule, Girish Meravanige Basavarajappa and Rakesh Kumar Tekade
    10. Drug-induced cardiotoxicity
    Vinayak Pawar, Yogesh Wankhede, Simranjit Kaur, Bhakti Pawar, Nupur Vasdev, Tanisha Gupta, Pinaki Sengupta and Rakesh Kumar Tekade
    11. Drug-induced immunotoxicity
    Mahi Mhatre, Suresh Shinde, Simranjit Kaur, Nupur Vasdev, Muktika Tekade, Bhakti Pawar, Adil Ali Sayyed and Rakesh Kumar Tekade
    12. Drug-induced photosensitivity
    Bhakti Pawar, Yogesh Wankhede, Gurpreet Banth, Muktika Tekade, Tanisha Gupta, Richa Dayaramani and Rakesh Kumar Tekade
    13. Toxic effects of cancer therapies
    Shweta Ingole, Nupur Vasdev, Muktika Tekade, Tanisha Gupta, Bhakti Pawar, Mahi Mhatre, Aprameya Ganesh Prasad and Rakesh Kumar Tekade
    14. High content screening in toxicology
    Mamata Panchal, Bhakti Pawar, Muktika Tekade, Nupur Vasdev, Tanisha Gupta, Piyush Gondaliya and Rakesh Kumar Tekade
    15. High-throughput screening in toxicity assessment
    Kuldeep Rajpoot, Mamata Panchal, Bhakti Pawar, Nupur Vasdev, Tanisha Gupta, Muktika Tekade, Manish Sharma and Rakesh Kumar Tekade
    16. Population pharmacokinetics/toxicokinetics
    Kuldeep Rajpoot, Muktika Tekade, Bhakti Pawar, Pinaki Sengupta and Rakesh Kumar Tekade
    17. Quantitative extrapolation interspecies scaling/low-dose extrapolation
    Shivam Otavi, Tanisha Gupta, Muktika Tekade, Amrita Singh, Pinaki Sengupta, Ashish Agrawal and Rakesh Kumar Tekade
    18. Toxicity and toxicodynamics of cryoprotectant used in pharmaceutical products
    Prashant L. Pingale, Amarjitsing P. Rajput, Yash S. Chavan, Rupali A. Patil, Amrita Singh and Rakesh Kumar Tekade
    19. Insect repellents as an environmental chemical toxicant to human health
    Pratik Katare, Suryanarayana Polaka, Lakshmi Vineela Nalla, Vaishali Makwana and Rakesh Kumar Tekade
    20. Clinical toxicity of antibodyedrug conjugates
    Tanisha Gupta, Mamata Panchal, Vinayak Pawar, Muktika Tekade, Sanyam Gandhi and Rakesh Kumar Tekade
    21. Cumulative toxicity of herbal drugs
    Anand More, Shweta Ingole, Tanisha Gupta, Nupur Vasdev, Muktika Tekade, Randa SH. Mansour and Rakesh Kumar Tekade
    22. Radiotherapy toxicity
    Mamata Panchal, Shubham Mule, Yogesh Wankhede, Muktika Tekade, Tanisha Gupta, Aprameya Ganesh Prasad and Rakesh Kumar Tekade
    23. Toxicities and toxicodynamic of anesthetics
    Simranjit Kaur, Md Abubakar, Bhaskar Jyoti Dutta, Bhakti Pawar, Muktika Tekade, Prashant L. Pingale and Rakesh Kumar Tekade
    24. Toxicity of nanomaterials
    Anoothi Bain, Nupur Vasdev, Muktika Tekade, Dinesh Kumar Mishra, Pinaki Sengupta and Rakesh Kumar Tekade
    25. Principles of management of acute poisoning
    Mahi Mhatre, Simranjit Kaur, Muktika Tekade, Maliheh Safavi and Rakesh Kumar Tekade
    26. Connecting link between pesticides and Parkinson’s disease
    Suryanarayana Polaka, Sivarupa Raji, Aditya Singh, Pratik Katare and Rakesh Kumar Tekade
    27. Psychopharmacology in late life: Key challenges and opportunities
    Shubham Mule, Vinayak Pawar, Muktika Tekade, Nupur Vasdev, Tanisha Gupta, Amrita Singh, Satyajit D. Sarker and Rakesh Kumar Tekade
    28. Ethical, legal, societal, and professional issues in toxicology
    Kuldeep Rajpoot, Shweta Ingole, Muktika Tekade, Bhakti Pawar, Tanisha Gupta, Pinaki Sengupta and Rakesh Kumar Tekade